Medical technology innovation, which is also knows as ‘MedTech’, has grown to become one of the main focuses for Deepbridge when seeking new companies to invest in. Andrew Aldridge, Partner and Head of Marketing at Deepbridge recently discussed the opportunities MedTech investment can bring.  

“Deepbridge Capital looks at three factors to identify the right companies for investment. Our primary focus is on whether innovation solves real commercial need. The second is whether the technology is protected by robust IP.  The third is the people involved: their drive is what makes a company successful. Deepbridge’s portfolio has always included MedTech opportunities thanks to their team’s experience and the company’s interest in supporting the vitally important issue of global healthcare provision.” 

Read more here. 

By following this link, you will leave the Deepbridge website. Deepbridge takes no responsibility for content on external websites.